Article info

Download PDFPDF

Extended report
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis

Authors

  1. Correspondence to Dr Philip J Mease, Swedish Medical Center and University of Washington, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA; pmease{at}philipmease.com
View Full Text

Citation

Mease PJ, Gottlieb AB, van der Heijde D, et al
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis

Publication history

  • Received October 25, 2016
  • Revised March 16, 2017
  • Accepted March 29, 2017
  • First published May 4, 2017.
Online issue publication 
August 10, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.